Chargement en cours...
Safe administration of chemotherapy in mast cell activation syndrome
INTRODUCTION: Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis and often occur in response to specific trigge...
Enregistré dans:
| Publié dans: | J Oncol Pharm Pract |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8193587/ https://ncbi.nlm.nih.gov/pubmed/33032491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155220953879 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|